Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Progyny (PGNY) PT Lowered to $18 at Canaccord Genuity
-
Canaccord Genuity Reiterates Buy Rating on Trupanion, Inc. (TRUP)
-
Kopin Corp (KOPN) Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Kopin Corporation Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Canaccord Genuity Reiterates Buy Rating on Mobileye N.V (MBLY)
-
Arq, Inc (ARQ) Announces Proposed Public Offering of Common Stock
-
Arq, Inc. Announces Proposed Public Offering of Common Stock
-
Mountaingate Capital Announces Sale of its Interest in Portfolio Company, Mars United Commerce, to Publicis Groupe
-
Driven Brands (DRVN) PT Raised to $20 at Canaccord Genuity
-
Canaccord Genuity Reiterates Buy Rating on HubSpot Inc (HUBS)
-
Canaccord Genuity Starts Santana Minerals Ltd (SMI:AU) at Spec. Buy
-
Offer Update – Lapsing of Acquisition
-
Cibus (CBUS) PT Lowered to $20 at Canaccord Genuity
-
Canaccord Genuity Starts ATHA Energy Corp. (SASK:CN) at Spec. Buy
-
Canaccord Keeps Buy Rating on Intuitive Machines Inc. (LUNR), Shares Gain ~46% on NASA Contract
-
Intention to launch an offer for subscription
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 17 09 2024] - (CGWL)
-
Form 8.3 - [ECKOH PLC - 17 09 2024] - (CGWL)
-
Blue Matter Acquires Sam Brown Inc., a Leading Healthcare Corporate Communications and Public Relations Agency
-
Canaccord Genuity Reiterates Buy Rating on Rocket Pharmaceuticals (RCKT)
-
Zevra Therapeutics, Inc. (ZVRA) PT Lowered to $22 at Canaccord Genuity
-
Canaccord Genuity Reiterates Buy Rating on Merit Medical Systems, Inc. (MMSI)
-
Form 8.3 - [ECKOH PLC - 16 09 2024] - (CGWL)
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 16 09 2024] - (CGWL)
-
Canaccord Genuity Reiterates Buy Rating on Passage Bio Inc. (PASG)
-
Canaccord Genuity Reiterates Buy Rating on Exact Sciences (EXAS)
-
Canaccord Genuity Reiterates Buy Rating on Arcturus Therapeutics (ARCT)
-
Sportradar Group AG (SRAD) PT Raised to $18 at Canaccord Genuity
-
EdgeTI Announces Closing of Private Placement Financing
-
Deveron Announces Closing of Final Tranche of Private Placement
-
MicroStrategy (MSTR) PT Lowered to $173 at Canaccord Genuity
-
MindMed (MNMD) PT Lowered to $14 at Canaccord Genuity
-
Vizsla Silver (VZLA) Announces 25M Share Offering at $2.60/sh
-
VIZSLA SILVER ANNOUNCES $65 MILLION BOUGHT DEAL FINANCING
-
Roscan Gold Announces Changes to the Board of Directors
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 13 09 2024] - (CGWL)
-
Form 8.3 - [ECKOH PLC - 13 09 2024] - (CGWL)
-
VIZSLA SILVER UPDATES AT-THE-MARKET EQUITY PROGRAM
-
Form 8.3 - [ECKOH PLC - 12 09 2024] - (CGAML)
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 12 09 2024] - (CGWL)
-
AirBoss Announces Board Changes
-
Canaccord Genuity Reiterates Buy Rating on Exact Sciences (EXAS)
-
Canaccord Genuity Reiterates Hold Rating on BioMarin Pharmaceutical Inc. (BMRN)
-
Canaccord Genuity Reiterates Buy Rating on Tesla (TSLA)
-
Canaccord Genuity Reiterates Buy Rating on HubSpot Inc (HUBS)
-
Wedgemount Closes Second Tranche of Over-Subscribed Debenture Offering
-
Canto Acquires Image Relay
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 11 09 2024] - (CGWL)
-
Canaccord Genuity Reiterates Buy Rating on Solo Brands (DTC)
-
Vivid Seats Inc. (SEAT) PT Lowered to $7 at Canaccord Genuity

